 Bank of New York Mellon Corp boosted its stake in Kindred Biosciences Inc NASDAQ:KIN by 3.3 during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission SEC. The fund owned 113,747 shares of the biopharmaceutical companys stock after acquiring an additional 3,684 shares during the period. Bank ... 